CCL3 and chronic obstructive pulmonary disease: Well tolerated in human model for COPD.In vitro and in vivo models showed reduction of leukocyte infiltration, inhibition of neutrophil influx in the lungs of rat model, and inhibition of CCL3 chemotaxis of human monocytes.